|
🐜
|
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
10 auth.
S. Verlohren,
A. Galindo,
D. Schlembach,
H. Zeisler,
I. Herraiz,
M. Moertl,
...
J. Pape,
J. Dudenhausen,
B. Denk,
H. Stepan
|
8 |
2010 |
8
🐜
|
|
🐜
|
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
12 auth.
S. Verlohren,
I. Herraiz,
O. Lapaire,
D. Schlembach,
M. Moertl,
H. Zeisler,
...
P. Calda,
W. Holzgreve,
A. Galindo,
T. Engels,
B. Denk,
H. Stepan
|
8 |
2012 |
8
🐜
|
|
🐜
|
2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
26 auth.
C. Lees,
C. Lees,
N. Marlow,
A. V. Wassenaer-Leemhuis,
B. Arabin,
C. Bilardo,
C. Brezinka,
S. Calvert,
J. Derks,
A. Diemert,
J. Duvekot,
E. Ferrazzi,
T. Frusca,
T. Frusca,
W. Ganzevoort,
...
K. Hecher,
P. Martinelli,
E. Ostermayer,
A. Papageorghiou,
D. Schlembach,
K. Schneider,
B. Thilaganathan,
T. Todros,
A. Valcamonico,
G. Visser,
H. Wolf
|
8 |
2015 |
8
🐜
|
|
🐜
|
New Gestational Phase–Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia
12 auth.
S. Verlohren,
I. Herraiz,
O. Lapaire,
D. Schlembach,
H. Zeisler,
P. Calda,
...
J. Sabria,
F. Markfeld-Erol,
A. Galindo,
K. Schoofs,
B. Denk,
H. Stepan
|
8 |
2014 |
8
🐜
|
|
🐜
|
Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta.
31 auth.
S. Collins,
B. Alemdar,
H. V. van Beekhuizen,
C. Bertholdt,
T. Braun,
P. Calda,
P. Delorme,
J. Duvekot,
L. Grønbeck,
G. Kayem,
J. Langhoff‐Roos,
L. Marcellin,
P. Martinelli,
O. Morel,
M. Mhallem,
...
M. Morlando,
L. N. Noergaard,
A. Nonnenmacher,
P. Pateisky,
P. Petit,
M. Rijken,
M. Ropacka-Lesiak,
D. Schlembach,
L. Sentilhes,
V. Stefanovic,
G. Strindfors,
B. Tutschek,
S. Vangen,
A. Weichert,
K. Weizsäcker,
F. Chantraine
|
7 |
2019 |
7
🐜
|
|
🐢
|
Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
7 auth.
W. Wallner,
R. Sengenberger,
R. Strick,
P. Strissel,
B. Meurer,
M. Beckmann,
...
D. Schlembach
|
7 |
2007 |
7
🐢
|
|
🐜
|
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia.
10 auth.
S. Verlohren,
S. Brennecke,
A. Galindo,
S. Karumanchi,
Ljiljana Mirković,
D. Schlembach,
...
H. Stepan,
M. Vatish,
H. Zeisler,
S. Rana
|
6 |
2021 |
6
🐜
|
|
🐬
|
Comparing uterine electromyography activity of antepartum patients versus term labor patients.
R. Garfield,
W. Maner,
L. MacKay,
D. Schlembach,
G. Saade
|
6 |
2005 |
6
🐬
|
|
🐜
|
Calibrated automated thrombin generation in normal uncomplicated pregnancy
8 auth.
A. Rosenkranz,
M. Hiden,
B. Leschnik,
Weiss Eva-Christine,
D. Schlembach,
U. Lang,
...
S. Gallistl,
W. Muntean
|
6 |
2008 |
6
🐜
|
|
🐬
|
Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
A. Bader,
D. Schlembach,
K. Tamussino,
G. Pristauz,
E. Petru
|
6 |
2007 |
6
🐬
|
|
🐜
|
Clinical utility of sFlt‐1 and PlGF in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restriction
7 auth.
H. Stepan,
A. Galindo,
M. Hund,
D. Schlembach,
J. Sillman,
D. Surbek,
...
M. Vatish
|
6 |
2022 |
6
🐜
|
